136 related articles for article (PubMed ID: 37275440)
21. Risk of malignancy in women who underwent hysterectomy for uterine prolapse.
Wan OY; Cheung RY; Chan SS; Chung TK
Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):190-6. PubMed ID: 23316927
[TBL] [Abstract][Full Text] [Related]
22. Incidence of unanticipated uterine pathology at the time of minimally invasive abdominal sacrocolpopexy.
Andy UU; Nosti PA; Kane S; White D; Lowenstein L; Gutman RE; Harvie HS
J Minim Invasive Gynecol; 2014; 21(1):97-100. PubMed ID: 23911564
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of Oophorectomy at the Time of Vaginal Hysterectomy in Patients with Pelvic Organ Prolapse.
Lua LL; Kosiorek HE; Wasson MN
J Minim Invasive Gynecol; 2019; 26(6):1063-1069. PubMed ID: 30343033
[TBL] [Abstract][Full Text] [Related]
24. The relationship between uterine prolapse and premalignant endometrial pathology.
Genc M; Celik E; Eskicioglu F; Bahar Gur E; Kurtulmus S; Gulec E; Guclu S
Clin Exp Obstet Gynecol; 2016; 43(4):500-503. PubMed ID: 29734535
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis.
Nicholson RC; Khunda A; Ballard P; Rees J; McCormick C
Int Urogynecol J; 2021 Dec; 32(12):3131-3141. PubMed ID: 34115164
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
27. [Should we perform intra-operative endometrial biopsy during pelvic reconstructive surgery with uterine preservation?].
Bohoussou E; Adjoussou SA; Letouzey V; Fatton B; de Tayrac R
J Gynecol Obstet Biol Reprod (Paris); 2014 Jan; 43(1):40-5. PubMed ID: 24309235
[TBL] [Abstract][Full Text] [Related]
28. SOGC clinical guidelines. Hysterectomy.
Lefebvre G; Allaire C; Jeffrey J; Vilos G; Arneja J; Birch C; Fortier M;
J Obstet Gynaecol Can; 2002 Jan; 24(1):37-61; quiz 74-6. PubMed ID: 12196887
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of perioperative complications and influencing factors of complications in 1 000 cases of robotic gynecological surgery].
Huang XT; Ji M; Zhao Z; He NN; Li Y; Xu PL; Zhang JF
Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):341-348. PubMed ID: 34034421
[No Abstract] [Full Text] [Related]
30. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
31. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
Chong W; Bui AH; Menhaji K
Am J Obstet Gynecol; 2020 Aug; 223(2):268.e1-268.e26. PubMed ID: 32413430
[TBL] [Abstract][Full Text] [Related]
32. Pelvic organ prolapse following hysterectomy on benign indication: a nationwide, nulliparous cohort study.
Husby KR; Gradel KO; Klarskov N
Am J Obstet Gynecol; 2022 Mar; 226(3):386.e1-386.e9. PubMed ID: 34688595
[TBL] [Abstract][Full Text] [Related]
33. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
[TBL] [Abstract][Full Text] [Related]
34. Incidental finding of abnormal cervical pathology in hysterectomy specimens after normal preoperative Papanicolaou smears in Thammasat University Hospital.
Chundarat PA; Suwannarurk K; Bhamarapravatana K; Pattaraarchachai J; Thaweekul Y; Mairaing K; Poomtavorn Y
Asian Pac J Cancer Prev; 2014; 15(14):5811-4. PubMed ID: 25081705
[TBL] [Abstract][Full Text] [Related]
35. Uterus conserving prolapse surgery--what is the chance of missing a malignancy?
Renganathan A; Edwards R; Duckett JR
Int Urogynecol J; 2010 Jul; 21(7):819-21. PubMed ID: 20135302
[TBL] [Abstract][Full Text] [Related]
36. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
[TBL] [Abstract][Full Text] [Related]
37. Clinical Characteristics and Histologic Features of Hysterectomy Specimens From Transmasculine Individuals.
Cao CD; Amero MA; Marcinkowski KA; Rosenblum NG; Chan JSY; Richard SD
Obstet Gynecol; 2021 Jul; 138(1):51-57. PubMed ID: 34259463
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for pelvic organ prolapse repair after hysterectomy.
Dällenbach P; Kaelin-Gambirasio I; Dubuisson JB; Boulvain M
Obstet Gynecol; 2007 Sep; 110(3):625-32. PubMed ID: 17766610
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
Parsons LHP; Pedersen R; Richardson DL; Kho KA
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
[TBL] [Abstract][Full Text] [Related]
40. Readmission and emergency department visits after minimally invasive sacrocolpopexy and vaginal apical pelvic organ prolapse surgery.
Berger AA; Tan-Kim J; Menefee SA
Am J Obstet Gynecol; 2021 Nov; 225(5):552.e1-552.e7. PubMed ID: 34437864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
